Randomized dose-ranging study of the safety and efficacy of WR 238605 (Tafenoquine) in the prevention of relapse of Plasmodium vivax malaria in Thailand
WR 238605 is an 8-aminoquinoline developed for the radical cure of Plasmodium vivax. Forty-four P. vivax-infected patients were randomly assigned to 1 of 4 treatment regimens: 3 groups received a blood schizonticidal dose of chloroquine followed by WR 238605: group A (n = 15) received 300 mg daily f...
Saved in:
Main Authors: | Douglas S. Walsh, Sornchai Looareesuwan, Polrat Wilairatana, D. Gray Heppner, Douglas B. Tang, Thomas G. Brewer, Watcharee Chokejindachai, Parnpen Viriyavejakul, Dennis E. Kyle, Wilbur K. Milhous, Brian G. Schuster, John Horton, David J. Braitman, Ralf P. Brueckner |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/25422 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse
by: Douglas S. Walsh, et al.
Published: (2018) -
Transmission-blocking activity of tafenoquine (WR-238605) and artelinic acid against naturally circulating strains of plasmodium vivax in Thailand
by: Narong Ponsa, et al.
Published: (2018) -
Tafenoquine for the prevention of Plasmodium vivax malaria relapse
by: James A. Watson, et al.
Published: (2022) -
Single-dose tafenoquine to prevent relapse of plasmodium vivax malaria
by: Marcus V.G. Lacerda, et al.
Published: (2020) -
Tafenoquine versus primaquine to prevent relapse of plasmodium vivax malaria
by: Alejandro Llanos-Cuentas, et al.
Published: (2020)